Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

about

Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis.Drug resistance and new therapies in colorectal cancer

P2860

Q33823686-5AC2B907-BA1F-4D43-813B-75DA59A96417 Q58740344-ADCC14F2-E1A3-4C2A-AE48-9FEC2EC0C5BB

P2860

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

Item

http://www.wikidata.org/entity/Q35580537

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Capecitabine and irinotecan wi ...... er: the phase II AVAXIRI study

@ast

Capecitabine and irinotecan wi ...... er: the phase II AVAXIRI study

@en

type

Item

label

Capecitabine and irinotecan wi ...... er: the phase II AVAXIRI study

@ast

Capecitabine and irinotecan wi ...... er: the phase II AVAXIRI study

@en

prefLabel

Capecitabine and irinotecan wi ...... er: the phase II AVAXIRI study

@ast

Capecitabine and irinotecan wi ...... er: the phase II AVAXIRI study

@en

P1476

Capecitabine and irinotecan wi ...... er: the phase II AVAXIRI study

@en

P2093

Amelia López-Ladrón

http://www.w3.org/2001/XMLSchema#string

Amparo Oltra

http://www.w3.org/2001/XMLSchema#string

Andrés Muñoz

http://www.w3.org/2001/XMLSchema#string

Bartomeu Massuti

http://www.w3.org/2001/XMLSchema#string

Bernardo Queralt

http://www.w3.org/2001/XMLSchema#string

Cristina Grávalos

http://www.w3.org/2001/XMLSchema#string

Encarna González-Flores

http://www.w3.org/2001/XMLSchema#string

Enrique Aranda

http://www.w3.org/2001/XMLSchema#string

Ferran Losa

http://www.w3.org/2001/XMLSchema#string

Manuel Chaves

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.

Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer.

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

The epidemiology of venous thromboembolism.

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

P2888

s12885-015-1293-y

P304

327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1293-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonia Salud

P577

2015-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275667898

http://www.w3.org/2001/XMLSchema#string

P6179

1027204734

http://www.w3.org/2001/XMLSchema#string

P698

25925749

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

bevacizumab

P932

4423590

http://www.w3.org/2001/XMLSchema#string

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

about

P2860

P2860

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P921

P932